Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2010
11/02/2010US7824675 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation
11/02/2010US7824674 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors
11/02/2010CA2621088C Genetically engineered fowlpox-based vaccine strain
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2406100C Dna transfection system for the generation of infectious influenza virus
11/02/2010CA2360252C Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2330170C Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
10/2010
10/28/2010WO2010124276A2 Anti-tgf-beta induction of bone cell function and bone growth
10/28/2010WO2010124188A1 Anti-human ror1 antibodies
10/28/2010WO2010124163A2 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
10/28/2010WO2010124154A1 Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation
10/28/2010WO2010124085A2 Compositions and methods for preventing and treating uterine disease
10/28/2010WO2010124009A2 Fully human anti-vegf antibodies and methods of using
10/28/2010WO2010123971A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010WO2010123891A1 Adjuvant cancer therapy
10/28/2010WO2010123845A2 Siderophore conjugate immunogenic compositions and vaccines
10/28/2010WO2010123813A1 Immunogenic epitopes of ngep antigen
10/28/2010WO2010123527A2 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/28/2010WO2010123524A1 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers
10/28/2010WO2010123519A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010WO2010123501A1 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010WO2010123124A1 Recurrence and prognosis factor for solid cancer, and use thereof for clinical purposes
10/28/2010WO2010123119A1 Therapeutic agent and screening method for inflammatory bowel disease
10/28/2010WO2010123069A1 Method for diagnosing autoimmune disease patient, in vitro diagnostic agent and therapeutic agent therefor
10/28/2010WO2010123012A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010WO2010122961A1 Method for preparing cell pharmaceutical
10/28/2010WO2010122460A1 Control of protein glycosylation and compositions and methods relating thereto
10/28/2010WO2010122310A2 Nucleic acid molecule
10/28/2010WO2010122217A1 A novel cell and therapeutical and diagnostical methods based thereon
10/28/2010WO2010122090A1 Fgfr1c antibody combinations
10/28/2010WO2010121923A1 Rspondin-3 inhibition in bone disorders
10/28/2010WO2010121618A1 A tuberculosis tb vaccine to prevent reactivation
10/28/2010WO2010101663A3 Live attenuated influenza virus vaccines comprising microrna response elements
10/28/2010WO2010077473A3 Monoclonal antibodies that react with the capsule of bacillus anthracis
10/28/2010WO2010063033A3 Recombinant avian influenza vaccine and uses thereof
10/28/2010WO2010042743A3 Chimeric multiplexes, compositions, and methods for using same
10/28/2010WO2010027499A3 Methods, compositions and vaccines relating to neisseria meningitidis antibodies
10/28/2010WO2010018378A8 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
10/28/2010US20100273992 Method for the production of an immunostimulating mucin (muc1)
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273238 Cellular Permissivity Factor for Viruses and Uses Thereof
10/28/2010US20100272805 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010US20100272788 Vaccines for malaria
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272786 Vaccine
10/28/2010US20100272785 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/28/2010US20100272776 Device including bone cage and method for treatment of disease in a subject
10/28/2010US20100272772 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
10/28/2010US20100272771 Device including bone cage and method for treatment of disease in a subject
10/28/2010US20100272760 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
10/28/2010US20100272759 Modified live vaccine of mycoplasma bovis, methods of producing modified live mycoplasma bovis vaccines, combination vaccines and methods of treatment
10/28/2010US20100272758 Viable non-toxic gram-negative bacteria
10/28/2010US20100272757 Bacillus anthracis protective antigen nucleic acid sequences
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272755 Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272753 Recombinant Adenovirus Vaccines
10/28/2010US20100272752 Vaccine for viruses that cause persistent or latent infections
10/28/2010US20100272751 Truncated l1 protein of human papillomavirus type 18
10/28/2010US20100272750 Hpv polyepitope constructs and uses thereof
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272748 Vaccine for protection against shigella sonnei disease
10/28/2010US20100272747 Polyvalent chimeric rubella virus-based vaccines
10/28/2010US20100272746 Lipoparticle comprising a protein and methods of making and using the same
10/28/2010US20100272745 Vaccines for malaria
10/28/2010US20100272744 OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof
10/28/2010US20100272743 Staphylococcus epidermidis nucleic acids and proteins
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272741 Immunity to folate receptors
10/28/2010US20100272740 Micro- and nanoscale devices for delivery of active fibronolytic agents
10/28/2010US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
10/28/2010US20100272738 Anti-ox40l antibodies and methods using same
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272736 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272734 Compositions and methods for increasing muscle growth
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272732 Emp2 antibodies and their therapeutic uses
10/28/2010US20100272731 Engineered anti-il-23p19 antibodies
10/28/2010US20100272730 Antigenic GM-CSF Peptides And Antibodies To GM-CSF
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272727 Compound for controlling appetite
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272725 Neisserial antigens
10/28/2010US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof
10/28/2010US20100272723 Optimized Antibodies that Target CD19
10/28/2010US20100272722 Therapeutic uses of inhibitors of RTP801
10/28/2010US20100272721 Treatment of cancer
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272717 Combinations of therapeutic agents for treating cancer
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272715 Variable antibodies
10/28/2010US20100272714 Anti-ADDL Antibodies and Uses Thereof
10/28/2010US20100272713 Genetic Markers Associated with Endometriosis and Use Thereof
10/28/2010US20100272712 Jnk3 as a target for the treatment of angiogenesis-related diseases
10/28/2010US20100272711 Compositions and methods for the treatment and prevention of cardiovascular diseases
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 1823